Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Hemoglobinopathies Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Summary

The global Hemoglobinopathies Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Hemoglobinopathies Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Hemoglobinopathies Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Gamida Cell
  • Alnylam Pharmaceuticals
  • Sanofi
  • Sangamo Therapeutics Inc.
  • Global Blood Therapeutics
  • Bluebird Bio
  • Emmaus Life Sciences Inc.
  • Prolong Pharmaceuticals
  • Celgene Corporation

By the Product Type, the market is primarily segmented into:

  • Blood Transfusion
  • Iron Chelation Therapy
  • Bone Marrow Transplant
  • Others
  • Market segment by Application, split into
  • Blood Testing
  • Genetic Testing
  • Pre-Implantation Genetic Diagnosis (PGD)
  • Others

By Applications, the market is segmented into:

  • Blood Testing
  • Genetic Testing
  • Pre-Implantation Genetic Diagnosis (PGD)
  • Others

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Hemoglobinopathies Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Hemoglobinopathies Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Hemoglobinopathies Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Hemoglobinopathies Market

The Hemoglobinopathies Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Hemoglobinopathies Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemoglobinopathies Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemoglobinopathies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Blood Transfusion
1.4.3 Iron Chelation Therapy
1.4.4 Bone Marrow Transplant
1.4.5 Others
1.5 Market by Application
1.5.1 Global Hemoglobinopathies Market Share by Application: 2020 VS 2026
1.5.2 Blood Testing
1.5.3 Genetic Testing
1.5.4 Pre-Implantation Genetic Diagnosis (PGD)
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Hemoglobinopathies Market Perspective (2015-2026)
2.2 Hemoglobinopathies Growth Trends by Regions
2.2.1 Hemoglobinopathies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemoglobinopathies Historic Market Share by Regions (2015-2020)
2.2.3 Hemoglobinopathies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Hemoglobinopathies Market Growth Strategy
2.3.6 Primary Interviews with Key Hemoglobinopathies Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathies Players by Market Size
3.1.1 Global Top Hemoglobinopathies Players by Revenue (2015-2020)
3.1.2 Global Hemoglobinopathies Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemoglobinopathies Market Concentration Ratio
3.2.1 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemoglobinopathies Revenue in 2019
3.3 Hemoglobinopathies Key Players Head office and Area Served
3.4 Key Players Hemoglobinopathies Product Solution and Service
3.5 Date of Enter into Hemoglobinopathies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Hemoglobinopathies Historic Market Size by Type (2015-2020)
4.2 Global Hemoglobinopathies Forecasted Market Size by Type (2021-2026)

5 Hemoglobinopathies Breakdown Data by Application (2015-2026)
5.1 Global Hemoglobinopathies Market Size by Application (2015-2020)
5.2 Global Hemoglobinopathies Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Hemoglobinopathies Market Size (2015-2020)
6.2 Hemoglobinopathies Key Players in North America (2019-2020)
6.3 North America Hemoglobinopathies Market Size by Type (2015-2020)
6.4 North America Hemoglobinopathies Market Size by Application (2015-2020)

7 Europe
7.1 Europe Hemoglobinopathies Market Size (2015-2020)
7.2 Hemoglobinopathies Key Players in Europe (2019-2020)
7.3 Europe Hemoglobinopathies Market Size by Type (2015-2020)
7.4 Europe Hemoglobinopathies Market Size by Application (2015-2020)

8 China
8.1 China Hemoglobinopathies Market Size (2015-2020)
8.2 Hemoglobinopathies Key Players in China (2019-2020)
8.3 China Hemoglobinopathies Market Size by Type (2015-2020)
8.4 China Hemoglobinopathies Market Size by Application (2015-2020)

9 Japan
9.1 Japan Hemoglobinopathies Market Size (2015-2020)
9.2 Hemoglobinopathies Key Players in Japan (2019-2020)
9.3 Japan Hemoglobinopathies Market Size by Type (2015-2020)
9.4 Japan Hemoglobinopathies Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Hemoglobinopathies Market Size (2015-2020)
10.2 Hemoglobinopathies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemoglobinopathies Market Size by Type (2015-2020)
10.4 Southeast Asia Hemoglobinopathies Market Size by Application (2015-2020)

11 India
11.1 India Hemoglobinopathies Market Size (2015-2020)
11.2 Hemoglobinopathies Key Players in India (2019-2020)
11.3 India Hemoglobinopathies Market Size by Type (2015-2020)
11.4 India Hemoglobinopathies Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Hemoglobinopathies Market Size (2015-2020)
12.2 Hemoglobinopathies Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemoglobinopathies Market Size by Type (2015-2020)
12.4 Central & South America Hemoglobinopathies Market Size by Application (2015-2020)

13Key Players Profiles
13.1 Gamida Cell
13.1.1 Gamida Cell Company Details
13.1.2 Gamida Cell Business Overview and Its Total Revenue
13.1.3 Gamida Cell Hemoglobinopathies Introduction
13.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2015-2020))
13.1.5 Gamida Cell Recent Development
13.2 Alnylam Pharmaceuticals
13.2.1 Alnylam Pharmaceuticals Company Details
13.2.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
13.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Introduction
13.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020)
13.2.5 Alnylam Pharmaceuticals Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Hemoglobinopathies Introduction
13.3.4 Sanofi Revenue in Hemoglobinopathies Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Sangamo Therapeutics Inc.
13.4.1 Sangamo Therapeutics Inc. Company Details
13.4.2 Sangamo Therapeutics Inc. Business Overview and Its Total Revenue
13.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Introduction
13.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2015-2020)
13.4.5 Sangamo Therapeutics Inc. Recent Development
13.5 Global Blood Therapeutics
13.5.1 Global Blood Therapeutics Company Details
13.5.2 Global Blood Therapeutics Business Overview and Its Total Revenue
13.5.3 Global Blood Therapeutics Hemoglobinopathies Introduction
13.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2015-2020)
13.5.5 Global Blood Therapeutics Recent Development
13.6 Bluebird Bio
13.6.1 Bluebird Bio Company Details
13.6.2 Bluebird Bio Business Overview and Its Total Revenue
13.6.3 Bluebird Bio Hemoglobinopathies Introduction
13.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2015-2020)
13.6.5 Bluebird Bio Recent Development
13.7 Emmaus Life Sciences Inc.
13.7.1 Emmaus Life Sciences Inc. Company Details
13.7.2 Emmaus Life Sciences Inc. Business Overview and Its Total Revenue
13.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Introduction
13.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2015-2020)
13.7.5 Emmaus Life Sciences Inc. Recent Development
13.8 Prolong Pharmaceuticals
13.8.1 Prolong Pharmaceuticals Company Details
13.8.2 Prolong Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Prolong Pharmaceuticals Hemoglobinopathies Introduction
13.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020)
13.8.5 Prolong Pharmaceuticals Recent Development
13.9 Celgene Corporation
13.9.1 Celgene Corporation Company Details
13.9.2 Celgene Corporation Business Overview and Its Total Revenue
13.9.3 Celgene Corporation Hemoglobinopathies Introduction
13.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2015-2020)
13.9.5 Celgene Corporation Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table
List of Tables

Table 1. Hemoglobinopathies Key Market Segments
Table 2. Key Players Covered: Ranking by Hemoglobinopathies Revenue
Table 3. Ranking of Global Top Hemoglobinopathies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemoglobinopathies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood Transfusion
Table 6. Key Players of Iron Chelation Therapy
Table 7. Key Players of Bone Marrow Transplant
Table 8. Key Players of Others
Table 9. Global Hemoglobinopathies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Hemoglobinopathies Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Hemoglobinopathies Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Hemoglobinopathies Market Share by Regions (2015-2020)
Table 13. Global Hemoglobinopathies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Hemoglobinopathies Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Hemoglobinopathies Market Growth Strategy
Table 19. Main Points Interviewed from Key Hemoglobinopathies Players
Table 20. Global Hemoglobinopathies Revenue by Players (2015-2020) (Million US$)
Table 21. Global Hemoglobinopathies Market Share by Players (2015-2020)
Table 22. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2019)
Table 23. Global Hemoglobinopathies by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Hemoglobinopathies Product Solution and Service
Table 26. Date of Enter into Hemoglobinopathies Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 29. Global Hemoglobinopathies Market Size Share by Type (2015-2020)
Table 30. Global Hemoglobinopathies Revenue Market Share by Type (2021-2026)
Table 31. Global Hemoglobinopathies Market Size Share by Application (2015-2020)
Table 32. Global Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 33. Global Hemoglobinopathies Market Size Share by Application (2021-2026)
Table 34. North America Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Hemoglobinopathies Market Share (2019-2020)
Table 36. North America Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 37. North America Hemoglobinopathies Market Share by Type (2015-2020)
Table 38. North America Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 39. North America Hemoglobinopathies Market Share by Application (2015-2020)
Table 40. Europe Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Hemoglobinopathies Market Share (2019-2020)
Table 42. Europe Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Hemoglobinopathies Market Share by Type (2015-2020)
Table 44. Europe Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Hemoglobinopathies Market Share by Application (2015-2020)
Table 46. China Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 47. China Key Players Hemoglobinopathies Market Share (2019-2020)
Table 48. China Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 49. China Hemoglobinopathies Market Share by Type (2015-2020)
Table 50. China Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 51. China Hemoglobinopathies Market Share by Application (2015-2020)
Table 52. Japan Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Hemoglobinopathies Market Share (2019-2020)
Table 54. Japan Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Hemoglobinopathies Market Share by Type (2015-2020)
Table 56. Japan Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Hemoglobinopathies Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Hemoglobinopathies Market Share (2019-2020)
Table 60. Southeast Asia Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Hemoglobinopathies Market Share by Type (2015-2020)
Table 62. Southeast Asia Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Hemoglobinopathies Market Share by Application (2015-2020)
Table 64. India Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 65. India Key Players Hemoglobinopathies Market Share (2019-2020)
Table 66. India Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 67. India Hemoglobinopathies Market Share by Type (2015-2020)
Table 68. India Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 69. India Hemoglobinopathies Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Hemoglobinopathies Market Share (2019-2020)
Table 72. Central & South America Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Hemoglobinopathies Market Share by Type (2015-2020)
Table 74. Central & South America Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Hemoglobinopathies Market Share by Application (2015-2020)
Table 76. Gamida Cell Company Details
Table 77. Gamida Cell Business Overview
Table 78. Gamida Cell Product
Table 79. Gamida Cell Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 80. Gamida Cell Recent Development
Table 81. Alnylam Pharmaceuticals Company Details
Table 82. Alnylam Pharmaceuticals Business Overview
Table 83. Alnylam Pharmaceuticals Product
Table 84. Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 85. Alnylam Pharmaceuticals Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Product
Table 89. Sanofi Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 90. Sanofi Recent Development
Table 91. Sangamo Therapeutics Inc. Company Details
Table 92. Sangamo Therapeutics Inc. Business Overview
Table 93. Sangamo Therapeutics Inc. Product
Table 94. Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 95. Sangamo Therapeutics Inc. Recent Development
Table 96. Global Blood Therapeutics Company Details
Table 97. Global Blood Therapeutics Business Overview
Table 98. Global Blood Therapeutics Product
Table 99. Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 100. Global Blood Therapeutics Recent Development
Table 101. Bluebird Bio Company Details
Table 102. Bluebird Bio Business Overview
Table 103. Bluebird Bio Product
Table 104. Bluebird Bio Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 105. Bluebird Bio Recent Development
Table 106. Emmaus Life Sciences Inc. Company Details
Table 107. Emmaus Life Sciences Inc. Business Overview
Table 108. Emmaus Life Sciences Inc. Product
Table 109. Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 110. Emmaus Life Sciences Inc. Recent Development
Table 111. Prolong Pharmaceuticals Business Overview
Table 112. Prolong Pharmaceuticals Product
Table 113. Prolong Pharmaceuticals Company Details
Table 114. Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 115. Prolong Pharmaceuticals Recent Development
Table 116. Celgene Corporation Company Details
Table 117. Celgene Corporation Business Overview
Table 118. Celgene Corporation Product
Table 119. Celgene Corporation Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 120. Celgene Corporation Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathies Market Share by Type: 2020 VS 2026
Figure 2. Blood Transfusion Features
Figure 3. Iron Chelation Therapy Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Others Features
Figure 6. Global Hemoglobinopathies Market Share by Application: 2020 VS 2026
Figure 7. Blood Testing Case Studies
Figure 8. Genetic Testing Case Studies
Figure 9. Pre-Implantation Genetic Diagnosis (PGD) Case Studies
Figure 10. Others Case Studies
Figure 11. Hemoglobinopathies Report Years Considered
Figure 12. Global Hemoglobinopathies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Hemoglobinopathies Market Share by Regions: 2020 VS 2026
Figure 14. Global Hemoglobinopathies Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Hemoglobinopathies Market Share by Players in 2019
Figure 17. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Hemoglobinopathies Revenue in 2019
Figure 19. North America Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Gamida Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Gamida Cell Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 28. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 30. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Sanofi Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 32. Sangamo Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Sangamo Therapeutics Inc. Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 34. Global Blood Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 36. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bluebird Bio Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 38. Emmaus Life Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Emmaus Life Sciences Inc. Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 40. Prolong Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 42. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Celgene Corporation Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us